| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/08/1995 | EP0637334A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization |
| 02/08/1995 | EP0637333A1 Ifn receptors recognition factors, protein sequences and methods of use thereof |
| 02/08/1995 | EP0637319A1 A novel anti-neoplastic cytokine |
| 02/08/1995 | EP0637318A1 Peptide derivatives corresponding to the carboxy terminal sequence of hirudin |
| 02/08/1995 | EP0386222B1 Process for preparing human serum albumine by fermenting a genetically engineered microorganism in the presence of a polyalkylene compound |
| 02/08/1995 | CN1098416A Process for producing hydrophobic polypeptides, proteins or peptides |
| 02/08/1995 | CN1098289A Immunle ribonucleic acid and transfer factor for resisting polytypic hepatitis and technology thereof |
| 02/07/1995 | US5387742 Transgenic mice displaying the amyloid-forming pathology of alzheimer's disease |
| 02/07/1995 | US5387676 MN gene and protein |
| 02/07/1995 | US5387673 Active fragments of fibroblast growth factor |
| 02/07/1995 | US5387670 Antibiotic, deoxymulundocandin, a process for its production and its use as medicament |
| 02/07/1995 | US5387414 Comprising peptide immunogen with novel epitopes |
| 02/07/1995 | US5387413 Anticoagulation by injecting a solution of a monoclonal antibody produced from hybridomas |
| 02/07/1995 | CA1334287C Biologically active peptides tan-866 |
| 02/02/1995 | WO1995003547A1 Methods for determining the invasiveness of a bladder tumor |
| 02/02/1995 | WO1995003422A1 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 02/02/1995 | WO1995003415A2 Epstein-barr virus dna sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests |
| 02/02/1995 | WO1995003414A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 02/02/1995 | WO1995003413A1 High level expression, purification and refolding of the neisseria meningitidis outer membrane group b porin proteins |
| 02/02/1995 | WO1995003409A1 Analogues of an anti-thrombin polypeptide and process for their preparation |
| 02/02/1995 | WO1995003408A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | WO1995003405A2 Enzymatic method for modification of recombinant polypeptides |
| 02/02/1995 | WO1995003402A1 EXPRESSION OF HUMAN INTERLEUKIN-1β IN A TRANSGENIC ANIMAL |
| 02/02/1995 | WO1995003397A1 Transgenic animal model for cognitive disorders |
| 02/02/1995 | WO1995003334A1 Antibodies specific for human prostate glandular kallikrein |
| 02/02/1995 | WO1995003333A2 Tryptase inhibitor |
| 02/02/1995 | WO1995003328A2 Melanoma-inhibiting protein |
| 02/02/1995 | WO1995003326A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | WO1995003325A1 Protegrins |
| 02/02/1995 | WO1995003324A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003323A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003322A1 Nickel-free hemoglobin and methods for producing such hemoglobin |
| 02/02/1995 | WO1995003321A1 Method for endomodification of proteins |
| 02/02/1995 | WO1995003318A1 Recombinant c140 receptor and its agonists and antagonists |
| 02/02/1995 | WO1995003069A1 Method for expression and purification of p2 protein from haemophilus influenzae type b |
| 02/02/1995 | WO1994029447A3 Dna coding for the human thyrotropin-releasing hormone receptor |
| 02/02/1995 | WO1994029446A3 Intracellular binding proteins and use thereof |
| 02/02/1995 | WO1994029350A3 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 02/02/1995 | WO1994026925A3 Processes for producing an enzyme |
| 02/02/1995 | WO1994018329A3 Serine protease variants having peptide ligase activity |
| 02/02/1995 | CA2168232A1 Recombinant c140 receptor and its agonists and antagonists |
| 02/02/1995 | CA2167808A1 Method for expression and purification of p2 protein from haemophilus influenzae type b |
| 02/02/1995 | CA2167677A1 Method for the high level expression, purification and refolding of the outer membrane group b porin proteins from neisseria meningitidis |
| 02/02/1995 | CA2167581A1 Transgenic animal model for cognitive disorders |
| 02/02/1995 | CA2167580A1 Expression of human interleukin-1.beta. in a transgenic animal |
| 02/02/1995 | CA2167303A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | CA2167302A1 Oncoprotein protein kinase |
| 02/02/1995 | CA2167267A1 Methods for determining the invasiveness of a bladder tumor |
| 02/02/1995 | CA2167091A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | CA2166870A1 Enzymatic method for modification of recombinant polypeptides |
| 02/02/1995 | CA2166788A1 Protegrins |
| 02/02/1995 | CA2166616A1 Nickel-free hemoglobin and methods for producing such hemoglobin |
| 02/02/1995 | CA2164221A1 Tryptase inhibitor |
| 02/01/1995 | EP0636696A1 Process for producing major histocompatibility antigen class ii protein and material having the same immobilized thereon |
| 02/01/1995 | EP0636694A2 Human and human-like thymopoietin, method for its production and recombinant DNA sequences encoding it |
| 02/01/1995 | EP0636623A1 Indole derivatives as 5-HT1- like agonists |
| 02/01/1995 | EP0636183A1 Compositions and methods for protein structural determinations |
| 02/01/1995 | EP0636182A1 Antibodies for treatment and prevention of respiratory syncytial virus infection |
| 02/01/1995 | EP0636180A1 T CELL EPITOPES OF THE MAJOR ALLERGENS FROM $i(AMBROSIA ARTEMISIIFOLIA) |
| 02/01/1995 | EP0636179A1 Oil-body proteins as carriers of high-value peptides in plants |
| 02/01/1995 | EP0636178A1 Protocadherin, their autibodies and uses |
| 02/01/1995 | EP0636177A1 ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN $g(b) SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E |
| 02/01/1995 | EP0636176A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily |
| 02/01/1995 | EP0636173A1 Treatment of hiv-associated immune thrombocytopenic purpura |
| 02/01/1995 | EP0636145A1 Synthetic polypeptides derived from the hiv envelope glycoprotein |
| 02/01/1995 | EP0636029A1 Antibodies specific for carcinoma-associated antigens |
| 02/01/1995 | EP0535150B1 Human macrophage inflammatory protein 2-beta |
| 02/01/1995 | EP0500736B1 Recombinant vaccine for porcine pleuropneumonia |
| 01/31/1995 | US5386025 Calcium channel compositions and methods |
| 01/31/1995 | US5386021 Mammalian guanine nucleotide binding protein with an ADP-rybosylation factor domain |
| 01/31/1995 | US5386013 A polypeptide glycoprotein having hyaluronic acid binding activity; antiinflammatory, antiarthritic, anticancer agents, infections |
| 01/31/1995 | US5385841 Increase production of extracellular enzyme or heterologous polypeptides |
| 01/31/1995 | US5385840 Respiratory system |
| 01/31/1995 | US5385740 Biologically active material characterized by catabolic activity generally associated with cachexia-inducing tumors, preparations, production and uses thereof |
| 01/31/1995 | CA2129156A1 High level expression of polypeptide that contains modified pres1 region of hepatitis b virus large antigen |
| 01/31/1995 | CA1334180C Antibiotics r106 |
| 01/31/1995 | CA1334177C Production of chimeric antibodies by homologous recombination |
| 01/31/1995 | CA1334176C Monoclonal antibody recognizing gamma atrial natriuretic polypeptide |
| 01/30/1995 | CA2126523A1 Jak kinases and regulation of cytokine signal transduction |
| 01/27/1995 | CA2128653A1 Nucleotide sequences allowing the replication and conservation of a genetic information in animal cells |
| 01/26/1995 | WO1995002823A1 Identification of ligands by selective amplification of cells transfected with receptors |
| 01/26/1995 | WO1995002751A1 Method for repairing a combustion chamber assembly |
| 01/26/1995 | WO1995002693A1 Bacillus thuringiensis isolates and toxins |
| 01/26/1995 | WO1995002692A1 Modified alpha-lactalbumin |
| 01/26/1995 | WO1995002686A1 Redirection of cellular immunity by receptor chimeras |
| 01/26/1995 | WO1995002684A1 Regulated apoptosis |
| 01/26/1995 | WO1995002683A1 Method of synthesizing saccharide compositions |
| 01/26/1995 | WO1995002612A1 Monoclonal antibodies to egg yolk immunoglobulins (igy) |
| 01/26/1995 | WO1994028125A3 Dna encoding prostaglandin receptor ep1 |
| 01/26/1995 | CA2167282A1 Regulated apoptosis |
| 01/26/1995 | CA2167157A1 Method of synthesizing saccharide compositions |
| 01/26/1995 | CA2167155A1 Modified alpha-lactalbumin |
| 01/26/1995 | CA2166711A1 Bacillus thuringiensis isolates and toxins |
| 01/25/1995 | EP0635575A1 Monoclonal antibodies against epitopes found in free but not in alpha-1-antichmotrypsin complexed prostate specific antigen |
| 01/25/1995 | EP0635573A2 Process for the preparation of native human glicentin |
| 01/25/1995 | EP0635132A1 Broadly reactive opsonic antibodies that react with common staphylococcal antigens |
| 01/25/1995 | EP0635064A1 Gustducin materials and methods |
| 01/25/1995 | EP0635059A1 Polysaccharide binding fusion proteins and conjugates |
| 01/25/1995 | EP0635056A1 Wild-type measles virus glycoproteins: vaccine and detection method therefor |
| 01/25/1995 | EP0635054A1 Mammalian melanocyte stimulating hormone receptors and uses |